The central
fact, and the one that helps to explain these insane recommendations,
is that the maker of hepatitis B vaccine, Merck, makes one
billion dollars a year from this vaccine.
A billion dollars
a year goes a long way toward influencing public policy.
Who
is behind this?
The group that
is pushing this through is called The Hepatitis B coalition.
Part of the Immunization Action Coalition, this group was
started by a $750,000 grant from the CDC. It is supported
by the World Health Organization, World Bank, Rockefeller
Foundation and ongoing funding from Smith-Kline, Merck, Aventis
and Johnson & Johnson.
Let us not forget
that it has been less than three years since the federal government
asked the drug companies to take mercury
out of this vaccine, and they still haven't complied.
I have seen
many dozens of children who were given this vaccine on the
first day of life and subsequently developed autism. Others,
like Michael Belkin's daughter, weren't as lucky and died
immediately after the vaccine.
Michael is a
successful Wall Street Financial analyst with his own company,
and has testified to Congress on this
issue and regularly forwards news health stories to me.
In the single-dose
hepatitis B vials, the drug companies have replaced the mercury
with aluminum, which is another potent neurotoxin that has
been associated with Alzheimer's.
But who knows what damage it will do to the immature central
nervous system of a one-day old infant.
The multi-dose
hepatitis B vials still contain mercury.
Folks, hepatitis
B is about as difficult to catch as AIDS. Namely, you nearly
always need to have blood or sexual contact of some sort.
That is why the main risk factors are IV drug abusers and
those who engage in sex with multiple partners.
Is
hepatitis vaccine safe?
The Vaccine
Adverse Event Reporting System (VAERS) was developed by the
government to report vaccine reactions. Many experts believe
that only 10% of the adverse reactions are reported though
as reporting is not mandated by law.
Even with only
10% of the problems being reported there were nearly 25,000
VAERS hepatitis B reports from July 1990 to October 31, 1998,
showing 439 deaths and 9673 serious reactions involving emergency
room visits, hospitalization, disablement or death.
The presence
of findings such as brain edema in healthy infants who die
very soon after receiving hepatitis B vaccine is profoundly
disturbing, especially in view of the frequency of neurological
symptoms in the VAERS.
Does
this make any sense?
Is
Hepatitis B vaccine effective in newborns?
Vaccine-derived
immunity is thought to be short-lived. Between 30-50% of vaccinated
individuals may lose their antibodies within 7 years.
Up to 60% of
persons who initially respond will lose detectable antibodies
within 12 years. So that means that these vaccines will provide
little to no protection to the real risks of acquiring hepatitis
B, promiscuous sexual behavior and IV drug abuse.
Does
this make any sense?
How
many children are hurt or helped by Hepatitis B vaccine?
Hepatitis B
is a rare, mainly blood-transmitted disease. In 1996 only
54 cases of the disease were reported to the CDC in the 0-1
age group. There were 3.9 million births that year, so the
observed incidence of hepatitis B in the 0-1 age group was
just 0.001%. In the Vaccine Adverse Event Reporting System
(VAERS), there were 1,080 total reports of adverse reactions
from hepatitis B vaccine in 1996 in the 0-1 age group, with
47 deaths reported.
Let us put this
in simpler terms. For every child with hepatitis B there were
20 that were reported to have severe complications. Let us
also remember that only 10% of the reactions are reported
to VAERS, so this means:
Traditional
medicine is harming 200 children to protect one from hepatitis
B.
Does
this make any sense?
How
serious i a Hepatitis B infection?
The numbers
speak for themselves.
Approximately
50% of patients who contract Hepatitis B develop no symptoms
after exposure.
However, the
exposure ensures that they will have life-time immunity. An
additional 30% develop only flu-like symptoms, and again,
this group will acquire life-time immunity.
Of the remaining
20% exposed to Hepatitis B will develop the symptoms of the
disease. 95% of this 20% will fully recover, with life-time
immunity.
Therefore, less
than 5% of people who contract Hepatitis B will become
chronic carriers of the infection.
The numbers
get even smaller: of that 5%, nearly 75% (or 3.75% of the
total exposed) will live with an asymptomatic infection and
only 25%, (or only 1.25% of the total number of people exposed)
will develop chronic liver disease or liver cancer, 10-30
years after the acute infection. (Hyams, K.C. (1995) Risks
of chronicity following acute hepatitis B virus infection:
A review. Clin. Infect. Dis. 20, 992-1000.)
Think of that
in terms of probability: the possibility of contracting the
disease is exceedingly difficult for children and only 1.25%
of those that are exposed will actually develop the most serious
complication!
This type of
a "protecting the needle in the haystack" medicine
is absurd at best, dangerous at worst.
Does
this make any sense?
How
many safety studies have been done on Hepatitis B vaccine?
None.
A manufacturer's
representative was asked in a 1997 Illinois Board of Health
hearing to show evidence that the hepatitis B vaccine is safe
for a 1-day old infant. The representative stated:
"We have
none. Our studies were done on 5- and 10-year-olds."
-- The Congressional
Quarterly, August 25, 2000, pg. 647
One would think
that these would be mandatory, but they are not. All that
is required is to show efficacy, (i.e. that the vaccine stimulates
an antibody response after it is give), not safety.
In most other
industries the fraud represented here would lead to criminal
charges.
Does
this make any sense?
What
can you do?
Please tell
every pregnant woman you know about this issue. They need
to know the facts BEFORE they are in the hospital and have
time to make an informed objective decision. If they are still
convinced their child needs hepatitis B vaccine, beg them
to make sure their child does not receive the vaccine as a
newborn. Delay the vaccine until they really are at a possible
risk, like late adolescence.
I have shown
dozens of times in this newsletter, drugs that are thought
to be safe are pulled from the market after they have killed
dozens or hundreds of people. I am hopeful that hepatitis
B vaccinations in newborns will be stopped. Medical science
will have to recognize the truth sooner or later.
Folks, drug
deaths pale in comparison to the devastation in lost lives
resulting from implementation of this hepatitis B recommendation.
You can play
a large role here. Most of all us did not have a chance to
make a difference in the 9/11 tragedy, but nearly everyone
of us can help protect the precious brain cells of a newborn.
Don't delay.
Contact every
pregnant woman you know immediately. Save a life.
Note
To Physicians:
I am a member
of the Association
of American Physicians and Surgeons (AAPS). This is a
group of over 10,000 US medical doctors, and most of us have
reached the conclusion
that the head of the organization, Dr. Jane Orient, has about
this issue.
To the extent
that the physician simply complies without making an independent
evaluation of the appropriateness of the vaccine for each
patient, he is abdicating his responsibility under the Oath
of Hippocrates to:
"prescribe
regimen for the good of my patients according to my ability
and my judgment and never do harm to anyone."
Related
Articles:
Beware
the FDA Approves Combined Hepatitis Vaccine
The
Fallacy of the Hepatitis A Vaccine
Hepatitis
B Vaccinations: Michael Belkin Testimony to Congress Tuesday
May 18, 1999
Hepatitis
B Vaccine
Mercury
in Vaccines
Autism
'Linked to Mercury Vaccine'
Follow
the Money on Vaccines